| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/11/2005 | CA2554410A1 Biotherapeutics, diagnostics and research reagents |
| 08/11/2005 | CA2554403A1 Gastrointestinal proliferative factor and uses thereof |
| 08/11/2005 | CA2554216A1 Methods and compositons for treating cancer |
| 08/11/2005 | CA2554185A1 Neuroprotective complex for treatment of cerebral ischemia and injury |
| 08/11/2005 | CA2554184A1 An efficient method to synthesize benzyl group-protected alpha-pentagalloylglucose (a-pgg) and its analogues |
| 08/11/2005 | CA2554166A1 Methods for reducing oxidative damage |
| 08/11/2005 | CA2554035A1 Corticotropin-releasing factor receptor 1 (crfr1) agonist polypeptides |
| 08/11/2005 | CA2553758A1 Use of aerosolized antithrombin to treat acute lung injury |
| 08/11/2005 | CA2553187A1 Heterodimeric follicle stimulating hormone-fc (fsh-fc) fusion proteins for the treatment of infertility |
| 08/11/2005 | CA2544978A1 Treatment of bone metastases by means of pth receptor agonists |
| 08/10/2005 | EP1561817A2 Modified CEA and uses thereof |
| 08/10/2005 | EP1561815A2 Tissue-specific and target rna-specific ribozymes |
| 08/10/2005 | EP1561807A1 Method of degrading hardly degradable protein |
| 08/10/2005 | EP1561757A1 Modified factor VIII |
| 08/10/2005 | EP1561470A1 HCV vaccines comprising the envelope-1 (E1) protein or the corresponding DNA and at least one antiviral agent |
| 08/10/2005 | EP1561469A1 Activated Protein C Formulations |
| 08/10/2005 | EP1561468A1 Pharmaceutical antidiabetic composition |
| 08/10/2005 | EP1561466A2 Boronic acid salts and use thereof in the preparation of medicaments for treating thrombosis |
| 08/10/2005 | EP1560933A2 Methods and compositions for treating neurological disorders |
| 08/10/2005 | EP1560850A2 Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion |
| 08/10/2005 | EP1560849A1 Growth hormone variations in humans and its uses |
| 08/10/2005 | EP1560847A2 Acetylated hmgb1 protein |
| 08/10/2005 | EP1560593A1 Novel composition and methods for the treatment of immune related diseases |
| 08/10/2005 | EP1560592A1 Treatment of hypersensitivity conditions |
| 08/10/2005 | EP1560591A2 Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto |
| 08/10/2005 | EP1560590A2 Synthetic complementary peptides and ophthalmologic uses thereof |
| 08/10/2005 | EP1560587A1 Cholesterol efflux and uses thereof |
| 08/10/2005 | EP1560558A1 Use of 3-position cyclosporin derivatives for hair growth |
| 08/10/2005 | EP1560540A2 Methods of treating dry eye disease with lantibiotics |
| 08/10/2005 | EP1368340B1 Piperazine derivatives as melanocortin receptor agonists |
| 08/10/2005 | EP1357936A4 BIOCATALYTIC AND BIOMIMETIC GENERATION OF NITRIC OXIDE i IN SITU /i AT SUBSTRATE/BLOOD INTERFACES |
| 08/10/2005 | EP1331931B1 Treatment of tinnitus |
| 08/10/2005 | EP1299114B1 Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase |
| 08/10/2005 | EP1292697A4 Method for preparing a physiologically active il-18 polypeptide |
| 08/10/2005 | EP1228028B1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 08/10/2005 | EP1208103B1 Reverse-turn mimetics and methods relating thereto |
| 08/10/2005 | EP1178813B1 Method of stimulating growth in aquatic animals using growth hormones |
| 08/10/2005 | EP1169441B8 Pharmaceutical compositions for the treatment of heart failure |
| 08/10/2005 | EP1154787B1 Synergistic combination comprising an interferon and a nucleoside with an antiflaviviral and antirhabdoviral effect |
| 08/10/2005 | EP1084145B1 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 08/10/2005 | EP1042359B1 Kappa receptor opioid peptides |
| 08/10/2005 | EP1003898B1 Integrin-targeting vectors having transfection activity |
| 08/10/2005 | EP0939652B1 Use of antibodies to cd45ro leukocyte antigen for immunomodulation |
| 08/10/2005 | EP0914150B1 Recombinant neospora antigens and their uses |
| 08/10/2005 | EP0909274B1 Method for purification of erythropoietin binding protein |
| 08/10/2005 | EP0837883B1 Method of solubilizing, purifying, and refolding protein |
| 08/10/2005 | EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides |
| 08/10/2005 | EP0776175B1 Therapeutic homeopathic dilutions of growth factors and use |
| 08/10/2005 | CN1653179A Cartilage regeneration using chondrocyte and TGF-beta |
| 08/10/2005 | CN1653177A Muteins of placental growth factor type 1, preparation method and application thereof |
| 08/10/2005 | CN1653125A Amelioration of the development of cataracts and other ophthalmic diseases |
| 08/10/2005 | CN1653089A Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 08/10/2005 | CN1653088A Improved synthetic lipid mixtures for the preparation of a reconstituted surfactant |
| 08/10/2005 | CN1653087A Collagen and method for producing same |
| 08/10/2005 | CN1653086A Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis C virus |
| 08/10/2005 | CN1653084A Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 08/10/2005 | CN1653080A Lymphatic and blood endothelial cell genes |
| 08/10/2005 | CN1653079A Intercalator containing pseudonucleotide(s) |
| 08/10/2005 | CN1652820A Methods of treatment using CTLA-4 antibodies |
| 08/10/2005 | CN1652814A Induction of antigen specific immunologic tolerance |
| 08/10/2005 | CN1652813A Pharmaceutical compositions comprising mannose binding lectin |
| 08/10/2005 | CN1652812A Combination product comprising an anti-coagulant and anti-arrhythmic oxabispidenes |
| 08/10/2005 | CN1652811A A combination product comprising melagatran and an anti-arrhythmic oxabispidenes |
| 08/10/2005 | CN1652810A Immunosuppressant compounds, methods and uses related thereto |
| 08/10/2005 | CN1652795A Compositions and methods for treating emphysema |
| 08/10/2005 | CN1652786A Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 08/10/2005 | CN1652785A Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident |
| 08/10/2005 | CN1652770A Use of statins and other immunomodulatory agents in the treatment of autoimmune disease |
| 08/10/2005 | CN1652750A Taste masked compositions of erythromycin A and derivatives thereof |
| 08/10/2005 | CN1652749A Co-grinding process for the preparation of a ternary composition |
| 08/10/2005 | CN1652698A Method and dietary composition for improving lipid digestibility |
| 08/10/2005 | CN1652697A Method and dietary composition for improving fat digestibility |
| 08/10/2005 | CN1652696A Method of improving absorption of vitamin E by a pet animal |
| 08/10/2005 | CN1652695A Method of improving growth performance of animal |
| 08/10/2005 | CN1651919A CD154 blockade monoclone antibody use for inhibiting rejection of insulin producing tissue transplantation |
| 08/10/2005 | CN1651461A Polyethylene glycol modified and recombined human interleukin and its preparation method |
| 08/10/2005 | CN1651457A Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens |
| 08/10/2005 | CN1651091A Sodium alginate microglobule blood vessel suppositery containing gynecoiatry medicine and its preparation method |
| 08/10/2005 | CN1651087A Combination of organic compounds |
| 08/10/2005 | CN1651079A Shu xue tong (blood coursing free flowing) freeze dried powder snjection agent and its preparation method |
| 08/10/2005 | CN1651078A Medicinal composition for anti tumour and antisenility |
| 08/10/2005 | CN1651077A New use of gene reconstituted urokin as origin |
| 08/10/2005 | CN1651076A Method of extracting rainbow conk saccharide peptide for injection in rainbow conk saccharided peptide crude product obtained from submerged fermentation |
| 08/10/2005 | CN1651075A Therapeutic application of cone shell toxin SO3 |
| 08/10/2005 | CN1651074A Use of neurotoxin therapy for treatment of urologic and related disorders |
| 08/10/2005 | CN1651073A Rat acarpous medicine and its preparation method |
| 08/10/2005 | CN1651072A Medicine for treating piglet white scour and its preparation method |
| 08/10/2005 | CN1651071A CD154 blockade therapy for therapeutic protein inhibitor syndrome |
| 08/10/2005 | CN1214115C Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug |
| 08/10/2005 | CN1214114C Activatable recombinant neurotoxins |
| 08/10/2005 | CN1214044C ErdB3 antibodies |
| 08/10/2005 | CN1214042C Production process for intravenous immune serum globulin and resultant product |
| 08/10/2005 | CN1214040C Peptide derivatives having thiazolyl-alanine residue |
| 08/10/2005 | CN1214006C Novel vitamin D derivatives with cyclopropyl rings in lateral chains, its production method and intermediate and utilization thereof for producing medicaments |
| 08/10/2005 | CN1213774C Technology for preparation of biological dressing material |
| 08/10/2005 | CN1213768C Method of treating endotoxemia |
| 08/09/2005 | US6927317 Modulating ramp activity |
| 08/09/2005 | US6927290 Production of mixed acid anhydride and amide compound |
| 08/09/2005 | US6927288 Plant thermogenic genes and proteins |
| 08/09/2005 | US6927285 Genes for human telomerase reverse transcriptase and telomerase variants |